Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sigmoid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Fractures, Bone 1Emergence Delirium 1Colonic Neoplasms 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Neuroleptanalgesia × Clear all
NCT05068180 2021-10-06

Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients

RenJi Hospital

Phase 4 Unknown
200 enrolled
GastrointestinalGenitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Liver Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sigmoid Neoplasms, Stomach Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡